Vimarsana
Biggest News Aggregation in the World

Page 38 - Life Technologies News Today : Breaking News, Live Updates & Top Stories | Vimarsana

Stay updated with breaking news from Life Technologies. Get real-time updates on events, politics, business, and more. Visit us for reliable news and exclusive interviews.

Top News In Life Technologies Today - Breaking & Trending Today

A ligand-receptor interactome platform for discovery of pain mechanisms and therapeutic targets - Vimarsana News

A ligand-receptor interactome platform for discovery of pain mechanisms and therapeutic targets

Science for just $15 USD. Painful connections Chronic pain impairs quality of life, is challenging to treat, and accompanies various diseases. Wangzhou et al. integrated bulk and single-cell RNA sequencing of ligand and receptor gene expression in the dorsal root ganglion (DRG) and various peripheral cell types from humans and mice. Computational analysis of these data enabled the construction of a connectome of potential and cell type–specific interaction points between sensory nerves and innervated tissues. With validation in a mouse model of mechanical pain, their findings suggest that ...

[Full text] Bioactive Compounds from Germinated Brown Rice Protect Cardiomyocytes - Vimarsana News

[Full text] Bioactive Compounds from Germinated Brown Rice Protect Cardiomyocytes

Discussion There are several therapeutic approaches to bio-functional foods against cardiovascular diseases, both in experimental and clinical studies. Germinated Brown Rice (GBR) exerted its protective properties on cardiovascular diseases and related-cardiovascular metabolism dysfunction, including hypertension, hyperlipidemia, and diabetes. Here, this is the first study to represent the cardioprotective effect of GBR on cardiomyocyte-simulated I/R injury. The significant findings in this study indicated that simulation of I/R promoted the percentage of cell death and total cell apoptosis. ...

Xlife Sciences AG (XLS): Joint venture with anfass Life Technologies - Vimarsana News

Xlife Sciences AG (XLS): Joint venture with anfass Life Technologies

DGAP-News: Xlife Sciences AG / Key word(s): Merger 05.03.2021 / 07:30 Xlife Sciences AG (XLS): Joint venture with anfass Life Technologies Development of highly effective antibodies without animal testing Xlife Sciences AG and Solothurn-based anfass Life Technologies AG have entered a joint venture. Hence, the jointly founded Quadira Biosciences AG has access to the 3D CoSeedis(TM) technology platform of abc biopply ag. This unique 3D cell technology enables the replication of human tissue for reliable testing and characterization of antibodies without animal testing. Xlife's technology pla...

Whole Exome Sequencing Market Excessive Growth Opportunities Estimated to be Experienced 2021-2026 – KSU - Vimarsana News

Whole Exome Sequencing Market Excessive Growth Opportunities Estimated to be Experienced 2021-2026 – KSU

Whole Exome Sequencing Market Excessive Growth Opportunities Estimated to be Experienced 2021-2026 ResearchMoz has announced the addition of the “Whole Exome Sequencing Market Size, Status And Forecast 2021-2026"report to their offering. rmozFebruary 15, 2021   With a multi-disciplinary approach, ResearchMoz elaborates an extensive analysis of the historical, current and future outlook of the global Whole Exome Sequencing Market as well as the factors responsible for such a growth. Our highly dedicated professionals have inputted critical and accurate insights associated with every industr...

GenapSys Names Jason Myers CEO | Financial Buzz - Vimarsana News

GenapSys Names Jason Myers CEO | Financial Buzz

Posted on 306 GenapSys Inc. (GenapSys), the company behind the world’s first highly accurate, affordable, and accessible gene sequencer, today announced it has named Jason Myers as its Chief Executive Officer, effective February 15, 2021. He will also join the GenapSys Board of Directors. Myers will succeed Dr. Hesaam Esfandyarpour, founder and CEO of GenapSys since 2010, who will remain as Chairman. As a strong leader in the biotech industry with a demonstrated track record of scaling businesses and bringing innovative technolog...